Navigation Links
Silence Therapeutics Announces Positive Response by USPTO that Affirms Validity of Four Foundational RNAi Patents
Date:12/12/2011

nables functional delivery of siRNA molecules selectively to liver cells including hepatocytes.

Additionally, the Company has a platform of novel siRNA molecules based around its AtuRNAi chemical modification technology, which provides a number of advantages over conventional siRNA molecules. Silence's unique RNAi assets also include structural features for RNAi molecules and specific design rules for increased potency and reduced off-target effects of siRNA sequences.

The Company's lead internal drug candidate is Atu027, a liposomal formulation in clinical development for systemic cancer indications and one of the most clinically advanced RNAi therapeutic candidates in the area of oncology. Atu027 incorporates two of the Company's technologies, AtuRNAi and AtuPLEX™. Silence is currently conducting an open-label, single-centre, dose-escalation Phase I study with Atu027 in patients with advanced solid tumors involving single, as well as repeated, intravenous administration. Encouraging interim safety and pharmacokinetic data were presented at the American Society of Clinical Oncology Annual Meeting in June 2011. The study is expected to be completed in the first half of 2012.

The Company's RNAi therapeutic platform has received key validation through multiple partnerships with pharmaceutical companies including AstraZeneca, Dainippon Sumitomo, Pfizer/Quark, and Novartis/Quark. Silence is actively pursuing the establishment of additional partnerships. Silence Therapeutics has operations in both Berlin and London.

About the "Zamore Design Rule" patent families

The "Zamore Design Rule" patent families are based on the seminal research of Phillip D. Zamore, Ph.D. at the University of Massachusetts Medical School. Dr. Zamore is a Howard Hughes Medical Institute Investigator, the Gretchen Stone Cook Chair of Biomedical Sciences, and Professor of Biochemistry & Molecular Pharmacology at University of Massachusetts Medical School.
'/>"/>

SOURCE Silence Therapeutics Plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office
2. Silence Therapeutics Provides Corporate and Development Update
3. Silence Therapeutics Signs Collaboration With Mirna Therapeutics to Evaluate Delivery of Novel microRNA Therapeutics
4. Silence Therapeutics Issued Japanese Patent Covering its Core RNA Interference (RNAi) Technology
5. Silence Therapeutics Lead RNA Interference Therapeutic Prevents Spread of Cancer to Lungs
6. Silence Therapeutics Receives Comprehensive Protection for RNAi Structural Modification Technology in Single European Patent
7. Silence Therapeutics Partner Quark Signs Exclusive Option Agreement With Novartis for Development and Commercialisation of QPI-1002
8. Silence Therapeutics Expands RNAi Structural Modification IP Portfolio With Issuance of New U.S. Patent
9. Silence Therapeutics Issued Novel RNAi Patent Covering High-Value Cancer Target in United States
10. Silence Therapeutics Appoints New Vice President of Research
11. Silence Therapeutics to Present at 12th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... NEW YORK , Aug. 27, 2014 ... of Guggenheim Partners, today announced the hiring of veteran ... and senior equity analyst. Mr. Butler will focus on ... brings our team a wealth of experience and a ... Dante Ferrarie , Senior Managing Director and Head of ...
(Date:8/27/2014)... Aug. 27, 2014 Research and Markets ... Enzyme for Pulp & Paper Industry Report 2014" ... Enzyme for Pulp & Paper Industry Report 2014 is ... of the global enzyme for pulp & paper industry. ... the industry including definitions, classifications, applications and industry chain ...
(Date:8/27/2014)... Tris Pharma, a specialty pharmaceutical company focused ... it has been selected as an award winner in ... Awards for Excellence competition in the Business Expansion ... judges from SCORE (Counselors to America,s Small Business) and ... at a gala event to be held on October ...
(Date:8/27/2014)... After the boom of the energy ... beverage craze is going to be the stress relief ... use Stress Relief energy pattern which can be applied ... a beverage, including minerals, herbs and liquids. Stress Relief ... power into rapid recovery and helping to adapt more ...
Breaking Biology Technology:Guggenheim Securities Hires Analyst Charles "Tony" Butler to Expand Healthcare Coverage 2Global Enzyme for Pulp & Paper Industry Report 2014 2Tris Pharma Selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 3Stress Relief: 1 Way to De-Stress Your Beverage Formula 4
... 22 Kiadis Pharma announced today,that its lead ... by the European Medicines Agency (EMEA) for the ... an allogeneic bone marrow,transplantation., "Following the orphan ... lead,product ATIR(TM), this is another important milestone in ...
... cotton, altered to express the insecticide, Bt, not only reduces ... other nearby crops that have not been modified with Bt. ... and maximizing crop yields in the future. , The ... on Friday, 19 September. Science is the journal ...
... nanostructures which respond to stimuli, such as pH, heat ... and more efficient chemical reactors. , Being developed by ... reactions, momentum, and heat and mass transfer inside chemical ... reactor technology for the chemical, pharmaceutical and agrochemical industries. ...
Cached Biology Technology:EMEA Grants Kiadis Pharma Lead Product ATIR(TM) Orphan Drug Designation 2GM crops protect neighbors from pests 2
(Date:8/26/2014)... plasmonics and optical microresonators, researchers at the University ... optical amplifier (or laser) design, paving the way ... optical systems at the microscopic scale that amplify ... Gary Eden, a professor of electrical and computer ... are well-suited for routing optical power on a ...
(Date:8/26/2014)... and the PETA International Science Consortium, LTD (PISC) scientists ... World Congress on Alternatives and Animal Use in the ... use of animals in research, testing and medical training, ... oversight systems. , At the conference, which is being ... PISC will present seven oral and poster presentations, including: ...
(Date:8/25/2014)... reveals that the US has experienced widespread adoption ... cancer in recent years. The BJU International ... are more expensive than traditional surgeries, their costs ... began using robotic technologies in operations to remove ... of such robotic-assisted radical prostatectomy (RARP) procedures for ...
Breaking Biology News(10 mins):Symphony of nanoplasmonic and optical resonators produces laser-like light emission 2US has seen widespread adoption of robot-assisted cancer surgery to remove the prostate 2
... Aluminum toxicity, a global agricultural problem, halts root ... than half of the world,s arable land. For ... of aluminum damage the growing root. The popular understanding ... root system, blocking cell division, damaging DNA, and ultimately ...
... models and live cell experiments, biomedical engineers at the Johns ... human protein fragments that can slow or stop the growth ... Reporting online last week in the Proceedings of the ... could lead to developing treatments to fight diseases that depend ...
... WEST LAFAYETTE, Ind. - While cellulosic biofuels derived from ... potential to be more efficient and environmentally friendly than ... policies are needed to reap these benefits, says an ... Friday (Oct. 3) in the journal Science, ...
Cached Biology News:UC Riverside biochemists devise method for bypassing aluminum toxicity effects in plants 2UC Riverside biochemists devise method for bypassing aluminum toxicity effects in plants 3Discovery of natural compounds that could slow blood vessel growth 2More research needed to make good on biofuel promise, experts say 2
Synonym: modified Grace's Insect medium...
Eagle's Ham's amino acids; EHAA...
Schneider's Drosophila - Insect medium...
... protein separation by two-dimensional electrophoresis (2D-PAGE), ... package from Bio-Rad and protein identification ... to meet customers requirements regarding experimental ... format of the results permanent contact ...
Biology Products: